Cargando…

Comprehensive Analysis of Histone Modifications in Hepatocellular Carcinoma Reveals Different Subtypes and Key Prognostic Models

Histone modification, an important epigenetic mechanism, is related to the carcinogenesis of hepatocellular carcinoma (HCC). In three datasets, we screened 88 epigenetic-dysregulated PCGs (epi-PCGs) , which were significantly associated with HCC survival and could cluster HCC into three molecular su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Huikai, Mu, Han, Xiao, Yajie, Zhao, Zhikun, Cui, Xiaoli, Wu, Dongfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359864/ https://www.ncbi.nlm.nih.gov/pubmed/35957801 http://dx.doi.org/10.1155/2022/5961603

Ejemplares similares

Identification of key genes and important histone modifications in hepatocellular carcinoma
por: Liu, Yu-Xian, et al.
Publicado: (2020)

Comprehensive Bioinformatics Analysis of Key Methyltransferases and Demethylases for Histone Lysines in Hepatocellular Carcinoma
por: Zheng, Yang, et al.
Publicado: (2020)

Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma
por: Liu, Kwei-Yan, et al.
Publicado: (2018)

Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma
por: Huo, Junyu, et al.
Publicado: (2022)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Deng, Zenghua, et al.
Publicado: (2021)

Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine
por: Wu, Yichao, et al.
Publicado: (2020)

Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma
por: Ma, Xi, et al.
Publicado: (2020)

Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications
por: Duan, Jin-Ling, et al.
Publicado: (2021)

Proteome-wide identification of lysine 2-hydroxyisobutyrylation reveals conserved and novel histone modifications in Physcomitrella patens
por: Yu, Zhiming, et al.
Publicado: (2017)

Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma
por: Zhang, Lele, et al.
Publicado: (2020)

Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B‐related hepatocellular carcinoma
por: Chai, Xiaoqiang, et al.
Publicado: (2021)

Exploring the Interplay between Metabolism and Tumor Microenvironment Based on Four Major Metabolism Pathways in Colon Adenocarcinoma
por: Qiao, Xiaofang, et al.
Publicado: (2022)

The Prognostic and Therapeutic Role of Histone Acetylation Modification in LIHC Development and Progression
por: Gao, Ji, et al.
Publicado: (2023)

A Prognostic Gene Signature for Hepatocellular Carcinoma
por: Chen, Rong, et al.
Publicado: (2022)

Integrated tumor stromal features of hepatocellular carcinoma reveals two distinct subtypes with prognostic/predictive significance
por: Li, Wei, et al.
Publicado: (2019)

Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma
por: Qin, Zhongqiang, et al.
Publicado: (2023)

Novel Molecular Subtypes and Related Score Based on Histone Acetylation Modification in Renal Clear Cell Carcinoma
por: Wang, Shichao, et al.
Publicado: (2021)

BUB1 Is Identified as a Potential Therapeutic Target for Pancreatic Cancer Treatment
por: Li, Ming, et al.
Publicado: (2022)

Correlation between Tumor Microenvironment and Immune Subtypes Based on CD8 T Cells Enhancing Personalized Therapy of Gastric Cancer
por: Wu, Jianyu, et al.
Publicado: (2022)

Integrated Multiple “-omics” Data Reveal Subtypes of Hepatocellular Carcinoma
por: Liu, Gang, et al.
Publicado: (2016)

Comprehensive analysis of key lncRNAs in HCV-positive hepatocellular carcinoma
por: Liu, Jingqi, et al.
Publicado: (2020)

Histone posttranslational modifications predict specific alternative exon subtypes in mammalian brain
por: Hu, Qiwen, et al.
Publicado: (2017)

Post-Translation Modifications and Mutations of Human Linker Histone Subtypes: Their Manifestation in Disease
por: Kumar, Ashok, et al.
Publicado: (2023)

Global histone modifications in breast cancer and their prognostic significance
por: Green, AR, et al.
Publicado: (2006)

Molecular Subtyping and Survival Analysis of Osteosarcoma Reveals Prognostic Biomarkers and Key Canonical Pathways
por: Southekal, Siddesh, et al.
Publicado: (2023)

The mechanism of lncRNAs in the crosstalk between epithelial-mesenchymal transition and tumor microenvironment for early colon adenocarcinoma based on molecular subtyping
por: Liang, Hanlin, et al.
Publicado: (2022)

A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma
por: Tang, Hui, et al.
Publicado: (2022)

Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma
por: Dai, Weiyu, et al.
Publicado: (2021)

Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma
por: Ke, Shanjia, et al.
Publicado: (2022)

Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2022)

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Diagnostic and Prognostic Value of Protein Post-translational Modifications in Hepatocellular Carcinoma
por: Wang, Jing, et al.
Publicado: (2023)

LRP1B mutation associates with increased tumor mutation burden and inferior prognosis in liver hepatocellular carcinoma
por: Yu, Ge, et al.
Publicado: (2022)

Radiation-Induced CXCL12 Upregulation via Histone Modification at the Promoter in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Ahn, Hak Jun, et al.
Publicado: (2019)

Treatment beyond progression with chemo-immunotherapy in an advanced esophageal squamous cell carcinoma patient: a case report
por: Peng, Ping, et al.
Publicado: (2021)

Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes
por: Cao, Peng, et al.
Publicado: (2022)

Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma
por: Wang, Tianbing, et al.
Publicado: (2021)

Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
por: Su, Wen-Jing, et al.
Publicado: (2021)

Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma
por: Jiayu, Fang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e8adpmgm9l5rnnsa3okcp2nor6